Press Releases Search News Category Company ReleasesCompany StatementsFinancial ReleasesProduct Releases Year None202320222021202020192018201720162015201420132012201120102009200820072006 Date Title PDF Version Jul 02, 2020 Alexion Finalizes Settlement with the U.S. Securities and Exchange Commission Jul 02, 2020 Alexion Completes Acquisition of Portola Jun 29, 2020 ULTOMIRIS® (ravulizumab) Receives Marketing Authorization from European Commission for Adults and Children with Atypical Hemolytic Uremic Syndrome (aHUS) Jun 24, 2020 Alexion Announces Phase 3 Study of Weekly Subcutaneous ULTOMIRIS® (ravulizumab-cwvz) Met Primary Endpoint Jun 17, 2020 Alexion Charitable Foundation Announces First Rare Belonging® Grants Jun 17, 2020 Alexion to Present at the 2020 Bank of America Virtual Napa Biotech Conference Jun 04, 2020 Alexion to Present at the 41st Annual Global Goldman Sachs Healthcare Conference May 14, 2020 Alexion Announces Upcoming Data Presentations at the Virtual 25th Congress of the European Hematology Association May 06, 2020 Alexion Reports First Quarter 2020 Results May 05, 2020 Alexion to Present at the Virtual Bank of America Securities 2020 Healthcare Conference Pagination First page « first Previous page ‹ previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page next › Last page last » Displaying 51 - 60 of 626